Shandra Eisenga Human Cell and Tissue Product Safety Act

119-hr1082 — Shandra Eisenga Human Cell and Tissue Product Safety Act. Sponsored by Rep. Moolenaar, John R. [R-MI-2]. Introduced 2025-02-06. House bill. 119th Congress. Latest action: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

119-hr1082 119th Congress House
XML

Bill Activity

House
Introduced in House
2025-02-06
Introduced
2025-02-06
Introduced in House
Committee
2025-02-06
Referred to the House Committee on Energy and Commerce.
Committee
2025-04-29
Ordered to be Reported by Voice Vote.
Reported in House
2025-06-12
Committee
2025-06-12
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Committee
2025-06-24
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Engrossed in House
2025-06-23
House Floor Vote
2025-06-23
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Senate
Referred in Senate
2025-06-24
Received in Senate
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsor
Rep. Moolenaar, John R. [R-MI-2] (R), MI
Introduced
2025-02-06
Committees
Health, Education, Labor, and Pensions Committee; Energy and Commerce Committee
Subjects
Administrative law and regulatory procedures; Civil actions and liability; Congressional oversight; Department of Health and Human Services; Health programs administration and funding; Health promotion and preventive care; Organ and tissue donation and transplantation
Latest Action
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

No roll-call vote data available for this bill.

Explore This Bill

Investigate this bill → AI summary, roll-call breakdown, and full bill analysis